WHO | WHO has launched its first data call to establish a global overview of the pre-clinical pipeline of products that target the WHP Priority Pathogens, TB and/or Clostridium difficile. WHO is inviting companies, institutions and others to submit data on their pre-clinical projects by March 18, 2019. This initiative builds on WHO’s existing global analysis of therapeutics currently in clinical development.